Skip to content Skip to navigation

Research Funding Opportunities

Semiconductor Research Corp. Hardware Security Call for Research

Overview

Semiconductor Research Corp. (SRC) Hardware Security Program (HWS) member companies are pleased to solicit white papers for possible funding in 2021. This call, open to all domestic and foreign universities, may be addressed by an individual investigator or a research team. Our selection process is divided into two stages. Interested parties are requested to submit a 1-page white paper, which should identify what can be done in a three-year period beginning October 1, 2021. A successfully selected white paper will result in an invitation to submit a full proposal. These proposals will be further down-selected for SRC research contracts.

It is the intention of the members for selected projects to be reviewed and renewed annually, but we anticipate that a project will have a lifetime of 3 years to support the completion of a doctoral dissertation. SRC projects typically involve 1-2 graduate students. SRC expects to support each project up to $100K (USD) per year. 

The number and size of the contracts awarded will be determined by the availability of funds, and by the number of high-quality proposals. Each researcher may be involved in no more than two white papers.

Research Needs 

Our research needs are outlined in the Hardware Security Research Program needs document. Researchers should carefully review this document.

Timetable and Deadlines

  • Deadline to Submit White Papers - Thursday, May 6, 2021 11:59 PM EDT
  • Invitation to Submit Full Proposals - Monday, June 14, 2021
  • Deadline to Submit Full Proposals - Tuesday, July 13, 2021, 11:59 PM EDT
  • Winning Proposals Notified - Friday, August 20, 2021
  • New Programs Start - October 1, 2021

Please direct all technical questions to John Oakley, Research Program Director.

All other questions and responses should be directed to Mary Rehbein, Research Program Coordinator.

Innovative Medicines Accelerator (IMA) Regenerative Therapies for Neuromuscular Targets Request for Proposals

Purpose and Scope: Stanford University’s Innovative Medicines Accelerator (IMA) aims to accelerate the translation of scientific discoveries at Stanford University into new therapeutics that impact human health. The goal of this request for propoals is to promote research with the potential to rapidly transform basic and translational regenerative medicine into treatments for spinal muscular atrophy (SMA) and othe neuromuscular diseases. With support from the Spinal Muscular Atrophy (SMA) Foundation, Stanford’s Innovative Medicines Accelerator (IMA) is seeking proposals from Stanford faculty to address unmet needs in the drug development pipeline for SMA and other devastating neuromuscular diseases. The SMA Foundation is pursuing regenerative and cell-based therapies that will “rebuild” the nervous system and muscle that will not only impact SMA but other indications such as neurodegenerative diseases, muscular dystrophies, cachexia, and aging.

Support Provided: Selected projects will receive a university research award of up to $300,000 for one year. Please note that award recipients will receive the entire amount funded, as overhead costs will be covered separately. If a project achieves its goal and makes significant progress towards a therapy, robust additional funding and resources for preclinical development may be awarded.

Eligibility: All Stanford faculty with PI eligibility are welcome to apply. Previous research experience in SMA is not required.

Timeline: All application materials must be received by 5pm on April 30th, 2021.

Contact: For questions about the funding opportunity, please contact the program manager: Amy Jacobson, Ph.D., Scientific Program Manager, Stanford ChEM-H, amyjacob@stanford.edu

Innovative Medicines Accelerator (IMA) Human Experimental Biology - Request for Letters of Intent

Purpose and Scope: Stanford University’s Innovative Medicines Accelerator (IMA) aims to accelerate the prototyping of innovative medicines and vaccines, and to enable hypothesis-driven studies in human subjects. The IMA seeks to support research projects aimed at testing hypotheses in human subjects that, if validated, have the potential to pave the road to new medicines, vaccines and diagnostics or to enhanced clinical use of existing ones. Competitive projects will have a strong mechanistic basis or empirical rationale and will utilize the Stanford School of Medicine Clinical and Translational Research Unit (CTRU), where patients can be safely tested and/or treated. Research on SARS-CoV2 or COVID-19 is ineligible for support through this mechanism.

Support Provided: Applicants are expected to receive up to $100k for a 6- to 12-month workplan.  Projects may be fully or partially funded.

Eligibility: All Stanford faculty with PI eligibility, including faculty in the Clinical Educator line are welcome to apply.

Timeline: Selection of LOIs is estimated to be completed by April 19, 2021. The submission deadline for full proposals will be May 17, 2021. Final decisions on full proposals will be made by June 1, 2021.

Contact: For questions about the funding opportunity, please contact the program manager:
Elizabeth Sefton, Ph.D.
Scientific Program Manager, Stanford ChEM-H
esefton@stanford.edu

Harrington Discovery Institute Grant Funding Opportunities

1) HARRINGTON SCHOLAR-INNOVATOR AWARD
**M.D. required for eligibility. Open to physician-scientists in the U.S. and Canada.
Call Opens: March 8
Letters of Intent (LOI) Due: April 16, 2021


Harrington Discovery Institute (HDI) invites you to submit an LOI for the 2022 Harrington Scholar-Innovator Award. This grant supports all disease areas and is designed to advance your promising drug discovery research towards the clinic. In addition to grant funding, HDI provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.

Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.

Attached in a zip file (Download Link) is additional information on the Scholar-Innovator Award:
• One-Page Overview
• Frequently Asked Questions
• Grant Application Outline 
• Submission Instructions


Check out these short videos from Harrington Scholar-Innovators.
To submit an online application, go to HDI’s grant system and create an account. 
Questions? Email HDIQuestions@HarringtonDiscovery.org.



2) ADDF-HARRINGTON SCHOLAR AWARD
** Ph.D. or M.D. or equivalent required for eligibility. Open to researchers in the U.S., U.K. and Canada.
Call Opens: March 2
Letters of Intent (LOI) Due: April 23, 2021

Harrington Discovery Institute (HDI) and the Alzheimer’s Drug Discovery Foundation (ADDF) invite you to submit an LOI for the 2021 ADDF-Harrington Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to proteostasis and epigenetics. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are encouraged to apply. In addition to grant funding, HDI provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.

Pending how far an applicant makes it in the review process, Harrington Discovery Institute may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.

Attached in a zip file (Download Link) is additional information on the ADDF-Harrington Scholar Award:
• One-Page Overview
• Frequently Asked Questions
• Grant Application Outline
 

Check out these short videos from Harrington Scholars.
To submit an online application, go to ADDF’s funding system and create an account.
Application questions? Email grants@alzdiscovery.org or HDIQuestions@HarringtonDiscovery.org.

Takeda Immuno-Oncology Call for Proposals 2020

Takeda is a global, value-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda Oncology is currently moving a broad portfolio of innovative internal and external Immuno-Oncology assets into the clinic and are looking for to expand our research efforts on novel target identification and validation.

Application Timeline:

  • Short proposal submission due August 14th (EXTENDED to August 28th)
  • Notification of selected Short proposals October 2nd
  • Full proposal submission due October 30th
  • Announcement of awards Mid November

For More Information, Please Contact:

Sara Nakashima
Office of Technology Licensing
Sara.Nakashima@stanford.edu

Stanford School of Medicine - The Catalyst COVID RFA

The Catalyst COVID RFA is a funded effort supported by the leadership of Stanford Medicine to identify and implement COVID-inspired innovations coming from within the Stanford community.

We are seeking innovations based on our experiences with the COVID-19 pandemic, that can have a positive impact on patients, physicians, healthcare operations, and future societal readiness for population-scale issues. The emphasis of this RFA is on rapid clinical implementation of transformative innovations.

The goals of the program are to:

  • Identify new Stanford Community innovations  inspired by COVID-19, and that can have a lasting effect for the long-term.
  • Implement, perfect, and scale innovations for maximum impact
  • If appropriate, export  innovations through commercialization or open-source distribution

Who Can Apply: Anyone at Stanford, including all faculty, staff, and students with ready-to-implement innovative solutions to the challenges facing our patients and health system.

Extended Application Deadline:  August 3rd (midnight)

What Should Applicants Expect: our team will review submissions to the RFA and invite Stanford faculty, staff and investment community members to score and rate ideas based on a number of factors including impact to healthcare, marketability, novelty, and differentiation for Stanford.

The following resources may be allocated to submissions with the highest score:

  • Funding from $25K to $500K per innovation (budget justification required)
  • Implementation and strategic support
  • Business planning and market assessment
  • Regulatory and internal operations navigation

Example ideal submissions might include innovations that solve for better digital solutions for distance healthcare (e.g. remote monitoring and telehealth), enhanced personal protection equipment for patients and staff, or inexpensive, rapid testing solutions, to name a few.

SAMSUNG Global Research Outreach (GRO) Program

Deadlines:
Institutional representative (RPM/RMG or OSR) deadline: August 18, 2020
Full proposal deadline: August 25, 2020, 5pm PST via GRO online submission website

Eligibility:
• Stanford faculty with PI eligibility may apply to this program.
• This is a research grant, and per Stanford PIship policy, only faculty with PI eligibility may apply.
• Find the research themes below (sub-themes are available for download on the GRO website).

Amount of funding:
• Funding amounts typically range from $100K to $200K overall (direct and indirect costs) for one year.
• Download the PDF file of the specific research sub-theme to view the amount of funding per year (scroll to the bottom of the webpage).
• Stanford’s Industrial Contract Office (ICO) in the Office of Technology and Licensing (OTL)* has have confirmed that Samsung will provide full indirect cost reimbursement (which is in compliance with Stanford’s policy).

Purpose:
The SAMSUNG Global Research Outreach (GRO) Program is an important part of growing SAMSUNG Electronics's academic research engagement and collaboration platforms. World-class university researchers have been annually invited since 2009 to propose novel research ideas and to work with our R&D teams to foster technological innovation. This has resulted in actively collaborative relationships with over 150 leading universities worldwide. Selected GRO projects will be funded with one year. This project may be extended up to three years, based on annual research outcomes and necessity for further research partnership determined by SAMSUNG. Joint research proposals from multiple universities are welcome and acceptable. The GRO Program represents an opportunity for SAMSUNG and universities to build a mutually beneficial research relationship and we look forward to your participation. SAMSUNG does not require, and does not desire, to receive any information that may be deemed confidential by the university researcher or the university.

The 2020 GRO Program is seeking novel ideas in the following research themes:
 
• Ultralow-power Cryogenic Computing
• Metaphotonics for Next Information & Communication Technologies (ICT)
• Next generation DRAM/NAND
• Functional Oxide
• New Quantum Dot
• New Light Sensitive Materials
• Privacy Preserving Computing
• Machine Intelligence
• 6G communication systems
• Fundamental technology for semiconductor equipment
• Bulk Acoustic Wave

Questions? Please contact gro.usa@samsung.com or Lisa Chen in the Industrial Contracts Office (ICO-OTL)

Semiconductor Research Corporation (SRC)

SRC is soliciting white papers in the areas of:

  • AI Hardware (AIHW) – Opens May 27, 2020
  • Analog/Mixed-Signal Circuits, Systems, and Devices (AMS-CSD) – Opens June 1, 2020
  • Logic and Memory Devices (LMD) – Opens June 1, 2020
  • Nanomanufacturing Materials and Processes (NMP) – Opens June 1, 2020
  • Environment, Safety, and Health (ESH) – Opens June 1, 2020

Please note white papers addressing the needs in the corresponding Research Needs documents are to be uploaded by the deadline noted in each solicitation timeline. Each researcher may be involved in no more than two submissions per call. A selected white paper will result in an invitation to submit a full proposal for further consideration for a research contract.

Sanofi Innovation Awards (iAwards)

Internal deadline: June 8, 2020

Limited funding opportunity for faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver) involved in multi-therapeutic areas including: immuno-oncology, molecular oncology, and immunology & inflammation. Priority will be given to early stage therapeutics, novel disease targets, mechanisms and screening assays, new disease relevant animal models, biomarkers and technologies that improve drug discovery and development.  A university-wide internal selection process is required.